EWS forms some chimeric genes with other avian erythroblastosis virus E26 homologue (ets) family genes, such as etsrelated gene (ERG), ets translocation variant 1 (ETV1), fifth Ewing variant (FEV), and E1A enhancer-binding protein (E1AF). The chimeric protein produced by the EWS-FLI1 gene reportedly functions as a new transcriptional factor because the transcriptional activation domain within the N-terminal domain of the EWS protein is joined with the ETS DNA-binding domain of the FLI1 protein. Moreover, this chimeric protein appears to regulate the transcription of other genes. [12] [13] [14] [15] [16] [17] [18] [19] For instance, the cell cycle is reportedly inhibited by the binding of retinoblastoma (Rb) protein to E2 promoter binding factor (E2F). 20) However, once the Rb protein becomes phosphorylated, E2F separates from it; this leads to the formation of a complex of cyclin E and cyclin-dependent kinase 2 (CDK2). This complex induces the cell cycle to proceed from G 1 phase to S phase. 21) Moreover, an inhibitor of DNA binding 2 (Id2) gene is expressed by the EWS-ets chimeric genes; this protein binds to Rb protein and frees E2F and also induces the cell cycle to proceed from G 1 phase to S phase through the activities of cyclin E and CDK2. 22, 23) Here, we report that the use of an antisense oligodeoxynucleotide to down-regulate the EWS-FLI1 and EWS-ERG chimeric genes, thereby reducing the progression of the cell cycle to S phase. 24) was added to each cell culture (1ϫ10 6 cells/dish) in FBS-free medium, and oligomers were supplied every 24 h. These cells were incubated for between 0 and 96 h. All the cultures were compared with controls cultured under the same conditions but without the AS-ODN. The sense oligodeoxynucleotide (S-ODN) sequence corresponding to AS-ODN was also used as a control. Total RNA Extraction Total RNA was extracted from the cultured cells using an EASY Prep RNA extraction kit (TaKaRa, Shiga, Japan) and the acid guanidinium thiocyanate-phenol-chloroform method. The concentration of total RNA was determined using Gene Spec III (HITACHI, Tokyo, Japan) and a bioanalyzer (Agilent, CA, U.S.A.).
MATERIALS AND METHODS

Cell Lines and Cultures As shown in
Reverse Transcription Polymerase Chain Reaction (RT-PCR) An RNA PCR Kit (AMV) Ver. 3.0 (TaKaRa, Shiga, Japan) was used with the primer supplied by the manufacturer. RT was performed using oligo-dT. The mixture was annealed at 42°C for 30 min followed by incubation at 99°C for 5 min and then held at 4°C. The PCR conditions were one cycle of template denaturing at 94°C for 120 s followed by 24 cycles of denaturing at 94°C for 30 s, annealing at 60°C for 30 s, extension at 72°C for 60 s, and then holding at 4°C. The primer sequences and sizes are listed in Table 2 . The concentration of cDNA was determined using a bioanalyzer.
Quantitative Real-Time PCR Total RNA (0.8 mg) was subjected to a reverse transcription reaction using an RNA PCR Kit (AMV) Ver.3.0 (TaKaRa, Shiga, Japan) and the PCR products were detected using SYBR Premix EX Taq (TaKaRa, Shiga, Japan). Real-time RT-PCR Primer (Hs002) (TaKaRa, Shiga, Japan) was used as the amplification primer for glyceraldehyde-3-phosphate (GAPDH). The design and synthesis of the other amplification primers were performed using the TaKaRa Perfect Real-time support system (Id2: HA004874, E2F1: HA040830). Quantitative real-time PCR was carried out using a Smart Cycler II System (Cepheid, CA, U.S.A.). The relative level of gene expression was calculated by dividing by the expression of GAPDH as an internal marker.
Flow Cytometry Cells were collected by trypsinization and washed in phosphate-buffered saline (PBS). The cells were then washed once again in PBS and incubated with 1 ml of propidium iodide (PI, 50 mg/ml final concentration; Sigma, MO, U.S.A.) for 30 min in the dark at 4°C. The cell suspension was incubated with 0.25 mg/ml of RNase (Sigma, MO, U.S.A.) for 30 min at 37°C. The fluorescence of the cells treated with PI was measured using a Cytomics FC500 Flow Cytometer (Beckman Coulter, CA, U.S.A.). Statistical Analysis All experimental results were presented as the meanϮstandard deviation (S.D.) or standard error (S.E.). The statistical analysis was performed using an analysis of variance (ANOVA) and a significance level of pϽ0.05.
RESULTS AND DISCUSSION
We examined some AS-ODNs which we originally designed and have been reported 24) (data not shown). We used one of the most useful AS-ODNs to down-regulate EWS-ets chimeric genes and it was also one of the reported ASODNs. 24 ) Figure 1 shows the expression levels of the EWS-FLI1 and EWS-ERG chimeric genes several days after the addition of AS-ODN (Figs. 1A, B ) and gel-like images (Fig. 1C ). The relative gene expression level was each gene expression divided by the expression of GAPDH as an internal marker on the gel-like image. Figure 1A shows that EWS-FLI1 chimeric genes were expressed in two cell lines (the EWS (exon 10)-FLI1 (exon 5) chimeric gene was expressed in KP-EW-MS, and the EWS (exon 7)-FLI1 (exon 6) chimeric gene was expressed in SK-N-LO); these expression levels gradually decreased since 2 d after the addition of AS-ODN. However, the expression of the EWS-FLI1 chimeric gene was not observed in SCMC-ES1 (which contained the EWS (exon 7)-ERG (exon 6) chimeric gene) or the Jurkat (leukemia) cell line (which did not contain any EWS-ets chimeric genes). Figure 1B shows that the expression of the EWS-ERG chimeric gene was only found in SCMC-ES1, containing the EWS (exon 7)-ERG (exon 6) chimeric gene. The expression level of this chimeric gene began to decrease 1 d after the addition of AS-ODN. Therefore, this AS-ODN was very effective for the down-regulation of both EWS-FLI1 and EWS-ERG chimeric genes, although each effective time is different. Thus, this AS-ODN may be useful for the treatment of ES family tumors containing these chimeric genes, which are found in 88-95% of ES tumors. [8] [9] [10] The transition rate (as determined using flow cytometry) from the G 1 /G 0 phases to the S phase of the cell cycle after treatment with AS-ODN is shown in Fig. 2 2A-(c) ). While the rates for SK-N-LO, which contains an EWS-FLI1 chimeric gene, the rate had decreased at 48 h after the addition of AS-ODN and the rates at both 48 h and 96 h after AS-ODN treatment were significantly different from the rate at 0 h (pϽ0.01 and pϽ0.001, respectively) ( Figs. 2A-(b), 2B) . However, the transition rates from the G 1 /G 0 phases to the S phase of the cell cycle did not change in the MCF-7 (breast The level of Id2 gene expression concerning with the regulation of Rb and E2F proteins by AS-ODN or S-ODN treatment is shown in Fig. 3A . Both the expression of Id2 and E2F1 was observed in SK-N-LO cells, but only the expression of Id2 gene was suppressed by the addition of AS-ODN, with a significant difference noted at 4 h and 24 h after treatment (Fig. 3) . However, no significant increases in the expression of the E2F1 gene were noted at any time (Fig. 3B) .
The addition of S-ODN had no effect on the expression of these genes in SK-N-LO cells. Moreover, these two genes were minimally expressed in Jurkat cells without EWS-ets chimeric genes and their expressions were not suppressed or up-regulated by either AS-ODN or S-ODN. Therefore, AS-ODN may regulate proteins (e.g., Rb, E2F) that suppress cell growth in ESFTs by down-regulating Id2 genes without the regulation of E2F1 gene located its down-stream.
These results suggest that this AS-ODN against these chimeric genes may be useful for suppressing ESFT tumor growth and may be an important target for the treatment of ES patients. 
